Predictive Clinical and Biological Parameters in Gynecological Cancer

Overview

Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation

Full Title of Study: “Predictive Clinical and Biological Parameters in Gynecological Cancer – GC-BIO-IPC 2013-010″

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Basic Science
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2023

Interventions

  • Other: gynecological cancer
    • blood and tumor samples

Arms, Groups and Cohorts

  • Experimental: gynecological cancer
    • blood and tumor samples

Clinical Trial Outcome Measures

Primary Measures

  • molecular alteration in gynecological cancer
    • Time Frame: average of 4 weeks after diagnosis
    • gene expression level

Secondary Measures

  • relation between molecular alteration and clinical and histological characteristics
    • Time Frame: up to 10 years
    • hazard ratio between molecular alteration and clinico-histological characteristics

Participating in This Clinical Trial

Inclusion Criteria

  • gynecological cancer suspicion
  • age > 18
  • signed informed consent

Exclusion Criteria

  • emergency

Exclusion criteria after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Institut Paoli-Calmettes
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Dominique GENRE, MD, 33491223778, drci.up@ipc.unicancer.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.